INS and polycystic ovary syndrome: The prevalence of insulin resistance is between 44% and 70% (4, 8, 9), and it manifests as impaired insulin-mediated suppression of lipolysis and lipid oxidation (10, 11), resulting in increased serum FFAs in obese women with PCOS that are matched for body mass index (BMI) (12).